Maralixibat for itching from liver condition in pregnancy
Treatments studied
Part of Digestive system, Skin clinical trials.
This study tests a medication called maralixibat for treating intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching and can affect the baby. The goal is to see if it safely lowers bile acids and improves outcomes for you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 50 and have a healthy single pregnancy (not twins or more).
- You are between 20 and 34 weeks pregnant at the start of the study.
- You have been diagnosed with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching.
- Your bile acid level (a blood test) is 19 or higher.
- You are not planning to deliver within the next 7 days and do not have any concerning findings on fetal monitoring.
- You are not participating in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called maralixibat to see if it is safe and well-tolerated in pregnant women with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching. Participation may help manage your symptoms and provide important information about this potential treatment.
This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.
This study looks at bile acid levels and possible genetic changes in people with persistent pregnancy itching. The goal is to better understand the cause of intrahepatic cholestasis of pregnancy and related pregnancy outcomes.
This study tests whether a single injection of esketamine (a pain medicine related to ketamine) given during a cesarean section can reduce itching after the surgery in women with a pregnancy-related liver condition. If it works, it could help you feel more comfortable after your baby is born.
This study looks at how a pregnancy liver condition (intrahepatic cholestasis) affects the baby's breathing after birth. It compares newborns whose mothers had this condition (and took medication for it) with newborns whose mothers did not have any liver issues during pregnancy.
This trial tests an investigational medicine called linerixibat for people with primary biliary cholangitis (PBC) who have severe itching that hasn't responded to other treatments and who are at risk of serious complications from the itching. It aims to help reduce this itching and improve quality of life.
Hear when a new Intrahepatic Cholestasis of Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.